Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate 
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage 
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
First Western Ship Transits Strait of Hormuz Since Iran War Began 
San Jose, CA, July 12, 2017 -- Jan Marini Skin Research, Inc. (JMSR), a leading provider of professional skin care and aesthetic solutions, announced the promotion of John Connors to CEO in addition to his prior role as President of the company. Jan Marini will continue as Founder and Chairman of the Board.
|
|||
In addition to her key role in product research & development, Jan will strategically focus on expanding and developing key corporate accounts. “I didn’t grow JMSR by sitting behind a desk, and I believe my passion and real value lies in brand development and education.”
John Connors joined the company in late 2009 and has been instrumental to the significant rebranding of the company that has occurred since that time. JMSR has realigned virtually all key aspects of its Sales, Marketing & Clinical efforts with a designated goal of providing a dynamic range of clinically validated solutions to the aesthetic marketplace.
Jan Marini, Founder and Chairman of the Board, stated, “Over the last 7 plus years with Jan Marini, John has overhauled our strategic efforts in all key segments of our business. John’s leadership, vision and strategic skills make him the clear choice to take JMSR to the next level of success. I am excited for JMSR employees and our global customers with the appointment of John. I am additionally thrilled to take on my new expanded role, which will ultimately accelerate our objectives.”
Prior to his tenure with JMSR, John was with Cutera, Inc. for 10 years, where he held senior management roles which included EVP of Global Sales & Marketing.
John Connors, CEO and President of JMSR adds, “We have a tremendous opportunity to gain even further market success with these key corporate appointments. I am extremely confident that our talented team of employees will collectively take the JMSR brand to unchartered gains.”
About Jan Marini Skin Research, Inc.
A San Jose, CA, based company founded in 1994, Jan Marini Skin Research, Inc. is a recognized leader and innovator in the professionally dispensed skin care market segment. With multiple peer-reviewed published solutions and numerous industry innovations over the past 23 years, including the patented ingredient Thymosin Beta-4 and the first topical lipid-soluble Vitamin C product introduced to the market, JMSR’s two primary focuses are to provide innovated technologies that deliver proven measurable results and an unwavering commitment to the ongoing success of our customers.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/7937d609-7bbd-4635-8ee0-59fc1bf1f2fe
Kim Conley Jan Marini Skin Research 408-620-3611 [email protected]
